164 related articles for article (PubMed ID: 15668277)
1. Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes.
Stathopoulos EN; Sanidas E; Kafousi M; Mavroudis D; Askoxylakis J; Bozionelou V; Perraki M; Tsiftsis D; Georgoulias V
Ann Oncol; 2005 Feb; 16(2):240-6. PubMed ID: 15668277
[TBL] [Abstract][Full Text] [Related]
2. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
Xenidis N; Vlachonikolis I; Mavroudis D; Perraki M; Stathopoulou A; Malamos N; Kouroussis C; Kakolyris S; Apostolaki S; Vardakis N; Lianidou E; Georgoulias V
Ann Oncol; 2003 Jun; 14(6):849-55. PubMed ID: 12796021
[TBL] [Abstract][Full Text] [Related]
4. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes.
Jakub JW; Diaz NM; Ebert MD; Cantor A; Reintgen DS; Dupont EL; Shons AR; Cox CE
Am J Surg; 2002 Oct; 184(4):302-6. PubMed ID: 12383888
[TBL] [Abstract][Full Text] [Related]
5. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node.
Schreiber RH; Pendas S; Ku NN; Reintgen DS; Shons AR; Berman C; Boulware D; Cox CE
Ann Surg Oncol; 1999; 6(1):95-101. PubMed ID: 10030421
[TBL] [Abstract][Full Text] [Related]
6. Detection of micrometastasis in the sentinel lymph nodes in breast cancer.
Ishida M; Kitamura K; Kinoshita J; Sasaki M; Kuwahara H; Sugimachi K
Surgery; 2002 Jan; 131(1 Suppl):S211-6. PubMed ID: 11821813
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
[TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy in ductal carcinoma in situ patients.
Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer.
Tryfonidis K; Kafousi M; Perraki M; Apostolaki S; Agelaki S; Georgoulias V; Stathopoulos E; Mavroudis D
Clin Breast Cancer; 2014 Dec; 14(6):442-50. PubMed ID: 24958324
[TBL] [Abstract][Full Text] [Related]
10. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
[TBL] [Abstract][Full Text] [Related]
11. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study.
Solá M; Margelí M; Castellá E; Julian JF; Rull M; Gubern JM; Mariscal A; Barnadas A; Fraile M
BMC Cancer; 2011 Jun; 11():252. PubMed ID: 21679400
[TBL] [Abstract][Full Text] [Related]
13. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Lymph Nodes in Classic Invasive Lobular Carcinoma of the Breast: Cytokeratin Immunostain Ensures Detection, and Precise Determination of Extent, of Involvement.
Patel A; D'Alfonso T; Cheng E; Hoda SA
Am J Surg Pathol; 2017 Nov; 41(11):1499-1505. PubMed ID: 28877063
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.
Saloustros E; Perraki M; Apostolaki S; Kallergi G; Xyrafas A; Kalbakis K; Agelaki S; Kalykaki A; Georgoulias V; Mavroudis D
Breast Cancer Res; 2011 Jun; 13(3):R60. PubMed ID: 21663668
[TBL] [Abstract][Full Text] [Related]
18. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
20. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
